Most Recent
ACCC calls for $35M fine against Empower Institute
The Australia Competition and Consumer Commission is seeking a $35 million penalty against Empower Institute after the court found the vocational trainer engaged in unconscionable conduct by "duping" customers into enrolling in courses they could not afford.
CSIRO appeals ruling allowing changes to BASF GMO patent
The CSIRO is appealing a decision by the Commissioner of Patents that allowed chemical giant BASF to amend its application for a genetically modified organisms patent.
Court suppresses Ben Roberts-Smith accuser’s identity
A key prospective witness in the Ben-Roberts Smith defamation proceedings can continue to have her identity suppressed, after a judge found there was "sufficient risk" to her safety if it was revealed.
The class action reform proposals experts can’t swallow
Lawyerly spoke to ten class action experts on the release of the Australian Law Reform Commission’s highly anticipated report into the class action regime. While many of the ALRC’s proposals were expected -- and welcomed as sensible -- others were greeted with concern and skepticism. Here, we look at the most controversial of the 24 recommendations.
FWO launches first underpayment case under new onus of proof laws
The Fair Work Ombudsman is suing a sushi operator in a case which will, for the first time, utilise laws that put the onus of proof on employers to disprove underpayment allegations.
Labor government would ban unfair contract terms
A future Labor government would pass reforms that make unfair contract terms illegal and punishable by fines of up to $10 million.
Aerocare loses appeal of split shifts ruling
Aviation services company Aerocare has lost its appeal of a Fair Work Commission decision that shot down an enterprise agreement forcing employees to work split shifts.
Juno Pharmaceuticals settles trade mark dispute with Juno Therapeutics
Juno Pharmaceuticals has resolved its appeal of an IP Australia ruling that allowed Seattle-based Juno Therapeutics to extend protection of its namesake trade mark into Australia.
Class action report by ALRC recommends sweeping changes
Law firms would be able to charge contingency fees and the corporate disclosure obligations would go under the microscope as part of a shake-up of the class action regime recommended by the Australian Law Reform Commission.
Teva sues Pharmacor over Parkinson’s drug patent
Teva has taken generic drug maker Pharmacor to court for allegedly threatening to infringe its patent for a Parkinson's drug.